D. E. Shaw & Co., Inc. Forma Therapeutics Holdings, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $473,373 - $1.35 Million	-66,485 Reduced 80.59%	16,010 $319,000
Q2 2022 Aug 15, 2022	BUY	$5.1 - $10.0 $352,833 - $691,830	69,183 Added 519.7%	82,495 $568,000
Q1 2022 May 16, 2022	BUY	$8.34 - $14.69 $111,022 - $195,553	13,312 New	13,312 $124,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.